Health

  • June 18, 2026

    RFK Jr. Urges 1st Circ. To Reinstate His Vaccine Advisers

    U.S. Health Secretary Robert F. Kennedy Jr. told the First Circuit a Boston federal judge's decision to freeze his vaccine committee appointments lacks a legal foundation and has left the government paralyzed when it comes to vaccine policy.

  • June 18, 2026

    Mich. Panel Sanctions Atty Over AI-Hallucinated Cases

    A medical malpractice suit in the Michigan Court of Appeals led to financial sanctions against an attorney who the court said during litigation repeatedly cited nonexistent cases that were generated by artificial intelligence.

  • June 18, 2026

    Cannabis World Cheers Justices' Gun Rights Ruling

    Cannabis industry stakeholders on Thursday largely applauded the U.S. Supreme Court's unanimous decision finding that a ban on gun ownership for drug users is unconstitutional as applied to a person who regularly uses marijuana.

  • June 18, 2026

    Gibson Dunn Hires Ropes & Gray Health Regulatory Atty In DC

    Gibson Dunn & Crutcher LLP has hired a former Ropes & Gray LLP partner who works on a myriad of health regulatory and drug pricing matters, advising pharmaceutical manufacturers, investors and other entities on those issues, the firm announced Thursday.

  • June 18, 2026

    5 Big ERISA Litigation Developments From 2026's First Half

    The U.S. Supreme Court's acceptance of a petition challenging Intel's 401(k) investment lineup and a Fourth Circuit ruling unraveling a class of Genworth Financial retirement plan participants headlined the court developments that caught benefits attorneys' attention in the first six months of 2026. Here, Law360 looks at those and other noteworthy ERISA decisions.

  • June 18, 2026

    DeepSeek's Valuation Soars To $50B, Plus More Rumors

    Artificial intelligence company DeepSeek hit a $50 billion valuation following its latest funding round, the original backers of artificial intelligence company Manus are planning to buy the company back from Meta, and private equity shop KKR wants to buy a majority stake in the Indian business of Sweden's Medicover for at least $1 billion.

  • June 18, 2026

    Pharma Co. Says Machine Breakdown Triggered Coverage

    A pharmaceutical company said its insurers improperly denied coverage to fix an eye dropper bottle filling machine, arguing the machine's breakdown caused extensive interruption to business activities that would trigger the policy, according to a complaint removed to California federal court Wednesday.

  • June 18, 2026

    Health System Strikes Deal To End Tobacco Fee Suit

    Nonprofit health system Advocate Aurora Health reached a deal to close a proposed class action claiming it hit workers with an unlawful fee through their health plan if they used tobacco, according to a filing in Illinois federal court.

  • June 18, 2026

    High Court Bars Federal Review Of State Court Appeals

    The U.S. Supreme Court ruled Thursday that a legal doctrine designed to curtail duplicative litigation prevents parties who lose in state court from appealing in federal district court even if the state case is still pending.

  • June 17, 2026

    Eli Lilly Urges Full Fed. Circ. To Scrap Teva's $177M IP Win

    Eli Lilly & Co. urged the full Federal Circuit Wednesday to review a panel ruling that upheld Teva's $177 million jury verdict on headache drug patents, arguing that the panel's decision runs afoul of the justices' Amgen holding and "opens a truck-sized hole in enablement and written description law."

  • June 17, 2026

    Amazon Workers Ink $3M Deal In COVID Screening Wage Suit

    Amazon will pay $3 million to settle a class action filed in Pennsylvania federal court alleging it failed to compensate more than 30,000 hourly employees for time they spent off the clock to undergo COVID-19 health screenings during the pandemic in violation of state minimum wage laws, according to a Wednesday order. 

  • June 17, 2026

    Mental Health Co. To Face Wage Class Damages Trial

    A North Carolina federal judge ruled Wednesday that the mental healthcare company JMJ Enterprises LLC must face a second-phase damages trial after a jury found in February in favor of a collective of employees claiming that the company willfully broke federal and state wage laws by underpaying workers at group homes.

  • June 17, 2026

    Grocery Chain Says Aon Put $40M In Opioid Coverage At Risk

    Supermarket chain Giant Eagle on Wednesday hit insurance brokerage firm Aon with claims in Pennsylvania federal court that it jeopardized $40 million in coverage allegedly owed to the chain for settlement and defense costs in opioid litigation.

  • June 17, 2026

    Maya Kowalski Sues Ex-Atty Over Fees, Funding Loan

    Maya Kowalski, the subject of the Netflix documentary "Take Care of Maya," filed a malpractice suit against her former attorney on Wednesday, accusing him of charging excessive fees and improperly orchestrating an advance funding loan after winning a $213 million judgment.

  • June 17, 2026

    DC Judge Halts Prison Bureau's 'Near Total' Trans Care Ban

    A Washington, D.C., federal judge blocked the Bureau of Prisons from enforcing a "near total ban" on gender-affirming care for trans incarcerated people, ruling Wednesday the policy was "reverse engineered" to fit the Trump administration's directive barring funding of such care in prisons, violating the Administrative Procedure Act. 

  • June 17, 2026

    Medline, AdaptHealth Sued Over Deadly Hospital Bed Fire

    Medline Industries and AdaptHealth have been sued by the estate and daughter of a Connecticut woman who allegedly died after suffering burns over 47% of her body when an electric-powered hospital-style bed caught fire in a Newtown home.

  • June 17, 2026

    Sen. Committee Clears Drug Disclosure, Biosimilar Bills

    The U.S. Senate Committee on Health, Education, Labor and Pensions on Wednesday cleared two bills for full Senate review, tackling the gap between health and patent oversight agencies, and the need for more interchangeable biosimilars.

  • June 17, 2026

    FTC Claims Trans Health Org. Lied About Medical Consensus

    The Federal Trade Commission and several Republican-led states sued the World Professional Association for Transgender Health on Wednesday, telling a Texas federal court that the organization falsely touted a "medical consensus" while advocating for transgender healthcare for children.

  • June 17, 2026

    J&J Can't Get New Trial In $65.5M Minn. Talc Cancer Case

    A Minnesota state judge on Wednesday denied Johnson & Johnson's bid for a new trial in a case that resulted in a $65.5 million verdict in favor of a 37-year-old wife and mother who claimed that the company's talc baby powder caused her cancer, rejecting arguments about her husband's infidelity.

  • June 17, 2026

    ITC, Masimo Tell Full Fed. Circ. To Skip Apple Watch Review

    Masimo Corp. and the U.S. International Trade Commission have pushed back on Apple's request for full Federal Circuit rehearing of a panel decision finding an older version of the Apple Watch infringes Masimo's patents, saying Wednesday the case isn't exceptional enough for such scrutiny.

  • June 17, 2026

    Aetna Can't Bring Its Own Claims In $20M Air Ambulance Fight

    A Connecticut federal judge has agreed to throw out three Aetna entities' allegations that air ambulance operators misrepresented their services throughout an Independent Dispute Resolution award process, finding that the federal No Surprises Act bars the insurer's counterclaims.

  • June 17, 2026

    6th Circ. OKs 30-Month Medical Fraudster Kickback Sentence

    The Sixth Circuit has ruled in a published opinion that a 30-month prison sentence was correctly calculated for a Tennessee man who was convicted of violating federal anti-kickback laws with his fraudulent door-to-door medical marketing firm.

  • June 17, 2026

    DOJ's Pot Shift Leaves Key Questions For Cannabis Industry

    The Trump administration's recent moves to relax federal restrictions on marijuana through the administrative process will have unclear ramifications for all industry players unless Congress steps in to rewrite cannabis law, attorneys heard Wednesday.

  • June 17, 2026

    Glenmark Pharma Beats Suit Over Recalled Cholesterol Drugs

    A New Jersey federal judge Wednesday tossed a proposed class action that accused drugmaker Glenmark Pharmaceuticals of falsely representing that its statin cholesterol drugs were safe and effective despite a recall over its manufacturing practices, saying plaintiff consumers' lack of actual economic or physical injury meant they couldn't sue.

  • June 17, 2026

    NC Clinic, School District Must Face COVID Vax Challenge

    A North Carolina state appeals panel issued its second opinion in a lawsuit from the mother of a teenager who alleged he was vaccinated for COVID against his will, finding Wednesday that she adequately put forward constitutional claims and can pursue allegations against a school district and medical society clinic in trial court.

Expert Analysis

  • 11th Circ. May Bring Tectonic Shift To FCA Qui Tam Actions

    Author Photo

    The Eleventh Circuit's upcoming decision in Zafirov v. Florida Medical Associates, assessing whether the False Claims Act permits ordinary citizens to stand as officers of the federal government, could significantly limit private relators' ability to bring FCA actions, say attorneys at Saul Ewing.

  • AI-Generated Doc Ruling Guides Attys On Privilege Risks

    Author Photo

    A New York federal court's ruling, in U.S. v. Heppner, that documents created by a defendant using an artificial intelligence tool were not privileged, can serve as a guide to attorneys for retaining attorney-client or work-product privilege over client documents created with AI, say attorneys at Sher Tremonte.

  • To Survive FCA Actions, Small Cos. Must Take Offensive Steps

    Author Photo

    A fumbled response to False Claims Act allegations can doom lower-middle-market businesses, and with FCA enforcement hitting record levels for two years, smaller companies must have offensive strategies ready that focus their limited resources on defeating civil qui tam and federal criminal actions, says Derrelle Janey at Olshan Frome.

  • The Law Firm Merger Diaries: Leadership Strategy After Day 1

    Author Photo

    For law firm leaders, ensuring a newly combined law firm lives up to its promise, both in its first days of operation and well after, includes tough decisions, clear and specific communication, and cheerleading, says Peter Michaud at Ballard Spahr.

  • How US Liability Law Is Becoming The Primary Regulator Of AI

    Author Photo

    Comprehensive federal AI regulation remains fragmented and uncertain — but U.S. courts, applying long-standing doctrines of liability and responsibility, are actively shaping how AI systems are designed, deployed and governed, and companies are aligning their AI practices because courts may hold them accountable if they do not, says Alexander Lima at Wesco International.

  • Record FCA Recoveries Signal Intensified Healthcare Focus

    Author Photo

    In its recently released False Claims Act statistics, the U.S. government's emphasis on record healthcare recoveries and government-initiated healthcare matters last year indicates robust enforcement ahead, though the administration's focus on current policy objectives also extends beyond the healthcare sector, say attorneys at Epstein Becker.

  • Fed. Circ. In Jan.: On The Validity Of Expert Testimony

    Author Photo

    The Federal Circuit's recent decision in Barry v. DePuy, addressing whether expert testimony is admissible even if it does not strictly adhere to the court's claim construction, suggests that exclusion via a Daubert motion is appropriate only when the line to improper testimony is clearly crossed, say attorneys at Knobbe Martens.

  • Methods For Challenging State Civil Investigative Demands

    Author Photo

    Ongoing challenges to enforcement actions underscore the uphill battle businesses face in arguing that a state investigation is prohibited by federal law, but when properly deployed, these arguments present a viable strategy to resist civil investigative demands issued by state attorneys general, say attorneys at Troutman Pepper.

  • Calif.'s Civility Push Shows Why Professionalism Is Vital

    Author Photo

    The California Bar’s campaign against discourteous behavior by attorneys, including a newly required annual civility oath, reflects a growing concern among states that professionalism in law needs shoring up — and recognizes that maintaining composure even when stressed is key to both succeeding professionally and maintaining faith in the legal system, says Lucy Wang at Hinshaw.

  • A Potential Shift In FDA's Approach To Drug Trial Design

    Author Photo

    Recent guidance released by the U.S. Food and Drug Administration clarifying how Bayesian approaches — which combine prior knowledge with new data — may be used in clinical trials reflects the agency's continued interest in innovative trial designs that may accelerate drug approvals, say attorneys at Alston & Bird.

  • Opinion

    SNAP Rule Confusion Risks A Compliance Crisis

    Author Photo

    Recent Supplemental Nutrition Assistance Program food restriction waivers pose a compliance crisis for legal practitioners advising food retailers, amid higher costs and lack of a coherent national standard, says Tyson-Lord Gray at Yeshiva University’s Benjamin N. Cardozo School of Law.

  • Series

    Trivia Competition Makes Me A Better Lawyer

    Author Photo

    Playing trivia taught me to quickly absorb information and recognize when I've learned what I'm expected to know, training me in the crucial skills needed to be a good attorney, and reminding me to be gracious in defeat, says Jonah Knobler at Patterson Belknap.

  • What FDA Guidance Means For Future Of Health Software

    Author Photo

    Two significant final guidance documents released by the U.S. Food and Drug Administration last month reflect a targeted effort to ease innovation friction around specific areas, including singular clinical decision support recommendations and sensor-based wearables, while maintaining established regulatory boundaries, say attorneys at Covington.

  • Opinion

    Federal Preemption In AI And Robotics Is Essential

    Author Photo

    Federal preemption offers a unified front at a decisive moment that is essential for safeguarding America's economic edge in artificial intelligence and robotics against global rivals, harnessing trillions of dollars in potential, securing high-skilled jobs through human augmentation, and defending technological sovereignty, says Steven Weisburd at Shook Hardy.

  • Series

    Law School's Missed Lessons: What Cross-Selling Truly Takes

    Author Photo

    Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.